Real life effect of an epoietin alpha biosimilar Retacrit® on response to chemotherapy-induced anemia and fatigue at 16 weeks in elderly patients (ELDER) First published 03/04/2018 Last updated 03/04/2018 EU PAS number:EUPAS23428 Study Planned